| |  Online-Ressource |
|---|
| Verfasst von: | Ried, Michael [VerfasserIn]  |
|---|
| | Kovács, Julia [VerfasserIn] |
|---|
| | Markowiak, Till [VerfasserIn] |
|---|
| | Müller, Karolina [VerfasserIn] |
|---|
| | Huppertz, Gunnar [VerfasserIn] |
|---|
| | Koller, Michael T. [VerfasserIn] |
|---|
| | Winter, Hauke [VerfasserIn] |
|---|
| | Klotz, Laura Valentina [VerfasserIn] |
|---|
| | Hatz, Rudolf A. [VerfasserIn] |
|---|
| | Zimmermann, Julia [VerfasserIn] |
|---|
| | Passlick, Bernward [VerfasserIn] |
|---|
| | Schmid, Severin Thomas [VerfasserIn] |
|---|
| | Hassan, Mohamed [VerfasserIn] |
|---|
| | Eichhorn, Martin E. [VerfasserIn] |
|---|
| | Hofmann, Hans-Stefan [VerfasserIn] |
|---|
| Titel: | Hyperthermic intrathoracic chemotherapy (HITOC) after cytoreductive surgery for pleural malignancies |
|---|
| Titelzusatz: | a retrospective, multicentre study |
|---|
| Verf.angabe: | Michael Ried, Julia Kovács, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V. Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, Mohamed Hassan, Martin E. Eichhorn, and Hans-Stefan Hofmann |
|---|
| E-Jahr: | 2021 |
|---|
| Jahr: | 12 September 2021 |
|---|
| Umfang: | 16 S. |
|---|
| Fussnoten: | Gesehen am 03.03.2022 |
|---|
| Titel Quelle: | Enthalten in: Cancers |
|---|
| Ort Quelle: | Basel : MDPI, 2009 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 13(2021), 18, Artikel-ID 4580, Seite 1-16 |
|---|
| ISSN Quelle: | 2072-6694 |
|---|
| Abstract: | Abstract: In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity (particularly renal insufficiency). A retrospective, multicentre study of patients who underwent cytoreductive surgery (CRS) with cisplatin-based HITOC was performed. The study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation (GZ: RI 2905/3-1)). Patients (n = 350) with malignant pleural mesothelioma (n = 261; 75%) and thymic tumours with pleural spread (n = 58; 17%) or pleural metastases (n = 31; 9%) were analyzed. CRS was accomplished by pleurectomy/decortication (P/D: n = 77; 22%), extended P/D (eP/D: n = 263; 75%) or extrapleural pneumonectomy (EPP: n = 10; 3%). Patients received cisplatin alone (n = 212; 61%) or cisplatin plus doxorubicin (n = 138; 39%). Low-dose cisplatin (≤125 mg/m2 BSA) was given in 67% of patients (n = 234), and high-dose cisplatin (>125 mg/m2 BSA) was given in 33% of patients (n = 116). Postoperative renal insufficiency appeared in 12% of the patients (n = 41), and 1.4% (n = 5) required temporary dialysis. Surgical revision was necessary in 51 patients (15%). In-hospital mortality was 3.7% (n = 13). Patients receiving high-dose cisplatin were 2.7 times more likely to suffer from renal insufficiency than patients receiving low-dose cisplatin (p = 0.006). The risk for postoperative renal failure is dependent on the intrathoracic cisplatin dosage but was within an acceptable range |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.3390/cancers13184580 |
|---|
| | Volltext: https://www.mdpi.com/2072-6694/13/18/4580 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1794603433 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Hyperthermic intrathoracic chemotherapy (HITOC) after cytoreductive surgery for pleural malignancies / Ried, Michael [VerfasserIn]; 12 September 2021 (Online-Ressource)
